Heidelberg Pharma AG (FRA:HPHA)

Germany · Delayed Price · Currency is EUR

3.130

+0.140 (4.68%)

At close: Jan 9, 2026

Revenue by Product

Financials in millions EUR. Fiscal year is December - November.

Millions EUR. Fiscal year is Dec - Nov.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2014 - 2018
Period Ending	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020	Nov '19 Nov 30, 2019	2014 - 2018
Antibody Drug Conjugates	9.86M	Log In	Log In	Log In	Log In	Upgrade
Antibody Drug Conjugates Growth	-46.75%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions EUR. Fiscal year is December - November.

Millions EUR. Fiscal year is Dec - Nov.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2014 - 2018
Period Ending	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020	Nov '19 Nov 30, 2019	2014 - 2018
China	4.74M	Log In	Log In	Log In	Log In	Upgrade
China Growth	-42.22%	Log In	Log In	Log In	Log In	Upgrade
United States	4.67M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-47.98%	Log In	Log In	Log In	Log In	Upgrade
Rest of the World	242.00K	Log In	Log In	Log In	Log In	Upgrade
Rest of the World Growth	-66.71%	Log In	Log In	Log In	Log In	Upgrade
Switzerland	145.00K	Log In	Log In	Log In	Log In	Upgrade
Switzerland Growth	178.85%	Log In	Log In	Log In	Log In	Upgrade
Germany	60.00K	Log In	Log In	Log In	Log In	Upgrade
Germany Growth	-89.07%	Log In	Log In	Log In	Log In	Upgrade